Standard BioTools Inc. (LAB)

USD 1.99

(-10.18%)

Revenue Summary of Standard BioTools Inc.

  • Standard BioTools Inc.'s latest annual revenue in 2023 was 106.34 Million USD , up 8.57% from previous year.
  • Standard BioTools Inc.'s latest quarterly revenue in 2024 Q3 was 44.96 Million USD , up 20.87% from previous quarter.
  • Standard BioTools Inc. reported a annual revenue of 97.94 Million USD in annual revenue 2022, down -24.99% from previous year.
  • Standard BioTools Inc. reported a annual revenue of 130.58 Million USD in annual revenue 2021, down -5.47% from previous year.
  • Standard BioTools Inc. reported a quarterly revenue of 45.54 Million USD for 2024 Q1, up 61.56% from previous quarter.
  • Standard BioTools Inc. reported a quarterly revenue of 37.2 Million USD for 2024 Q2, down -18.3% from previous quarter.

Annual Revenue Chart of Standard BioTools Inc. (2023 - 2001)

Historical Annual Revenue of Standard BioTools Inc. (2023 - 2001)

Year Revenue Revenue Growth
2023 106.34 Million USD 8.57%
2022 97.94 Million USD -24.99%
2021 130.58 Million USD -5.47%
2020 138.14 Million USD 17.83%
2019 117.24 Million USD 3.79%
2018 112.96 Million USD 10.82%
2017 101.93 Million USD -2.4%
2016 104.44 Million USD -8.95%
2015 114.71 Million USD -1.5%
2014 116.45 Million USD 63.6%
2013 71.18 Million USD 36.02%
2012 52.33 Million USD 22.09%
2011 42.86 Million USD 27.73%
2010 33.56 Million USD 32.06%
2009 25.41 Million USD 65.58%
2008 15.34 Million USD 110.96%
2007 7.27 Million USD 13.71%
2006 6.39 Million USD 0.0%
2001 130.58 Million USD 0.0%

Peer Revenue Comparison of Standard BioTools Inc.

Name Revenue Revenue Difference
Bionano Genomics, Inc. 36.11 Million USD -194.44%
Prenetics Global Limited 21.74 Million USD -389.084%
Star Equity Holdings, Inc. 45.78 Million USD -132.259%
CareDx, Inc 280.32 Million USD 62.065%
Exact Sciences Corporation 2.49 Billion USD 95.746%
Exagen Inc. 52.54 Million USD -102.367%
Inotiv, Inc. 572.42 Million USD 81.423%
Guardant Health, Inc. 563.94 Million USD 81.144%
Biodesix, Inc. 49.08 Million USD -116.636%
BioNexus Gene Lab Corp. 9.77 Million USD -988.344%
Precipio, Inc. 15.19 Million USD -599.743%
iSpecimen Inc. 9.92 Million USD -971.092%
Natera, Inc. 1.08 Billion USD 90.177%
Aspira Women's Health Inc. 9.15 Million USD -1061.678%
23andMe Holding Co. 219.63 Million USD 51.584%
Castle Biosciences, Inc. 219.78 Million USD 51.617%
Personalis, Inc. 73.48 Million USD -44.718%
Aclaris Therapeutics, Inc. 31.24 Million USD -240.299%
Applied DNA Sciences, Inc. 13.36 Million USD -695.515%
OpGen, Inc. 3.41 Million USD -3010.885%
T2 Biosystems, Inc. 7.19 Million USD -1378.382%
Myriad Genetics, Inc. 678.4 Million USD 84.325%
ICON Public Limited Company 8.12 Billion USD 98.69%
NeoGenomics, Inc. 591.64 Million USD 82.026%
Star Equity Holdings, Inc. 45.78 Million USD -132.259%
IDEXX Laboratories, Inc. 3.66 Billion USD 97.095%
RadNet, Inc. 1.61 Billion USD 93.422%
MDxHealth SA 70.19 Million USD -51.497%
Psychemedics Corporation 22.09 Million USD -381.22%
Illumina, Inc. 4.5 Billion USD 97.639%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 66.023%
DarioHealth Corp. 20.35 Million USD -422.504%
Fulgent Genetics, Inc. 289.21 Million USD 63.231%
Sera Prognostics, Inc. 306 Thousand USD -34651.634%
ENDRA Life Sciences Inc. - USD -Infinity%
OPKO Health, Inc. 863.49 Million USD 87.685%
Medpace Holdings, Inc. 1.88 Billion USD 94.361%
Neogen Corporation 924.22 Million USD 88.494%
Intelligent Bio Solutions Inc. 3.11 Million USD -3317.336%
Prenetics Global Limited 21.74 Million USD -389.084%
Mainz Biomed B.V. 895.47 Thousand USD -11775.209%
bioAffinity Technologies, Inc. 2.53 Million USD -4099.014%
Trinity Biotech plc 56.83 Million USD -87.113%
Neuronetics, Inc. 71.34 Million USD -49.044%
Sotera Health Company 1.04 Billion USD 89.866%
bioAffinity Technologies, Inc. 2.53 Million USD -4099.014%